We will post notifications regarding new coronavirus infectious diseases issued by the Ministry of Health, Labor and Welfare and the Tokyo Metropolitan Government for medical institutions, pharmacies, pharmaceutical sales businesses, etc.

• Allocation of oral antiviral drugs (pakilovid pack) to medical institutions and pharmacies in new coronavirus infection (Attachment, revision of Q&A collection) (PDF: 1,711KB)
  December 23, 2020 Ministry of Health, Labor and Welfare New Coronavirus Infectious Disease Control Headquarters, Pharmaceutical Affairs and Environmental Health Bureau General Affairs Division Administrative Contact
• Handling of general-use novel coronavirus/influenza virus antigen qualitative test kits during the simultaneous epidemic of new coronavirus infectious disease and seasonal influenza (PDF: 97KB)
  December 16, 2020
  PSEHB Notification No. 1216-1 Director, Medical Device Evaluation Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labor and Welfare Director of Monitoring, Guidance and Narcotics Division, Pharmaceutical Safety and Environmental Health Bureau
• Setting of consultation counter and cooperation request for stable supply of medical antipyretic analgesics, etc. (PDF: 721KB)
  December 14, 2020 Ministry of Health, Labor and Welfare Health Policy Bureau Pharmaceutical Industry Promotion and Medical Information Planning Division Office Contact
• About distribution of oral antiviral drug (Zokoba tablet 125mg) to medical institutions and pharmacies in new coronavirus infection (PDF: 1,046KB)
  Final revision December 12, 2020 Ministry of Health, Labor and Welfare Novel Coronavirus Infectious Disease Control Headquarters Pharmaceutical and Environmental Health Bureau General Affairs Division Office Contact
• Regarding orders for new coronavirus antigen test kits based on the outpatient medical system, etc. assuming simultaneous epidemic with seasonal influenza (cooperation request) (PDF: 1,918KB)
  Partially revised on December 9, 2020 Ministry of Health, Labor and Welfare Headquarters for Promotion of Novel Coronavirus Infectious Disease Control Ministry of Health, Labor and Welfare Health Policy Bureau Pharmaceutical Industry Promotion and Medical Information Planning Division
• Regarding the handling of medical antigen qualitative test kits at pharmacies under the simultaneous epidemic of new coronavirus infection and seasonal influenza (PDF: 2,753KB)
  December 9, 2020 Ministry of Health, Labor and Welfare Novel Coronavirus Infectious Disease Control Headquarters Ministry of Health, Labor and Welfare Pharmaceutical Affairs and Environmental Health Bureau General Affairs Division
• Points to note when selling general-use new coronavirus/influenza virus antigen qualitative test kits under the simultaneous epidemic of new coronavirus infectious disease and seasonal influenza (PDF: 407KB)
  December 9, 2020 Ministry of Health, Labor and Welfare Novel Coronavirus Infectious Disease Control Headquarters Ministry of Health, Labor and Welfare Pharmaceutical Safety and Environmental Health Bureau General Affairs Division Ministry of Health, Labor and Welfare, Pharmaceutical Safety and Environmental Health Bureau
• Handling of the expiry date of the Eversheld Intramuscular Injection Set (PDF: 101KB)
  November 30, 2020 Pharmaceutical Evaluation Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labor and Welfare
• Temporary handling under the Medical Law for online medical treatment utilization in response to new coronavirus infectious diseases and seasonal influenza (PDF: 128KB)
  November 29, 2020 Office contact, General Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• About inoculation promotion of vaccination for Omicron stock of medical worker (request) (PDF: 2,184KB)
  Public information poster 1 (PDF: 879KB) of inoculation within the year
  Public information poster 2 (PDF: 599KB) of inoculation within the year
  Leaflet (Omicron 1) (PDF: 620KB)
  Leaflet (Omicron 2) (PDF: 574KB)
  Vaccination leave and handling of working hours (PDF: 270KB)
  November 25, 2020 Office contact, General Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• Regarding orders for new coronavirus antigen test kits based on the outpatient medical system, etc. assuming simultaneous epidemic with seasonal influenza (cooperation request) (PDF: 263KB)
  Ministry of Health, Labor and Welfare Novel Coronavirus Infectious Disease Control Headquarters Ministry of Health, Labor and Welfare Health Policy Bureau Pharmaceutical Industry Promotion and Medical Information Planning Division
• About allocation to medical institution of neutralizing antibody drug "tixagebimab and silgavimab" in new coronavirus infectious disease (correction of Q&A) (PDF: 614KB)
  Final revision on November 22, 2022 Ministry of Health, Labor and Welfare New Coronavirus Infectious Disease Control Headquarters Office Contact
• Exceptions for drugs subject to emergency approval (PDF: 91KB)
  PSEHB Notification No. 1122-5 November 22, 2020 Director of Pharmaceutical Evaluation Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labor and Welfare Notification No. 1122-1, Director of Monitoring, Guidance and Drug Control Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labor and Welfare
• About distribution of oral antiviral drug (zokoba tablet 125mg) in new coronavirus infectious disease to medical institution and pharmacy (PDF: 899KB)
  November 22, 2020 Ministry of Health, Labor and Welfare New Coronavirus Infectious Disease Control Headquarters Pharmaceutical and Environmental Health Bureau General Affairs Division Office Contact
• About acceptance of attendant of supporter at the time of hospitalization of child with a disability who needs special communication support (PDF: 2,692KB)
  November 17, 2020 4 Fukubo Ian No. 764 Tokyo Metropolitan Government Bureau of Social Welfare and Public Health
• About the delivery start of the 2022 in-hospital infection control seminar (publication request) (PDF: 2,496KB)
  November 8, 2020 Ministry of Health, Labor and Welfare Health Policy Bureau Regional Medical Planning Division Office Contact
• Distribution of Neutralizing Antibody Drugs "Tixagevimab and Silgavimab" in New Coronavirus Infection to Medical Institutions (Attachments and Amendments to Q&As) (PDF: 293KB)
  October 6, 2020 Final revision Ministry of Health, Labor and Welfare New Coronavirus Infectious Disease Control Headquarters Office Contact
• Regarding the revision of "Q&A regarding temporary and exceptional handling of medical treatment using telephones and information communication devices during the spread of new coronavirus infectious disease" (Part 3) (PDF: 242KB)
  September 30, 2020 Medical Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare General Affairs Division, Pharmaceutical and Environmental Health Bureau, Ministry of Health, Labor and Welfare
• Regarding the distribution of oral antiviral drugs (Pakilobid® pack) to medical institutions and pharmacies in the new coronavirus infection (Attachment, question and answer collection, and reference material revision) (PDF: 668KB)
  September 27, 2020 Final revision Ministry of Health, Labor and Welfare Novel Coronavirus Infectious Disease Control Headquarters Pharmaceutical and Environmental Health Bureau General Affairs Division Office Contact
• Allocation, etc. to medical institutions and pharmacies due to the NHI drug price listing of oral antiviral drug (Lagebrio® Capsules) for novel coronavirus infection (Part 3) (publicity) (PDF: 118KB)
  September 15, 2020
  Ministry of Health, Labor and Welfare Novel Coronavirus Infectious Disease Control Headquarters Pharmaceutical and Environmental Health Bureau General Affairs Division Pharmaceutical and Environmental Health Bureau General Affairs Division
• Allocation, etc. to Medical Institutions and Pharmacies Accompanying NHI Drug Price Listing of Oral Antiviral Drug (Lagebrio® Capsules) for Novel Coronavirus Infection (Part 2) (Notice) (PDF: 209KB)
  September 8, 2020 Ministry of Health, Labor and Welfare Novel Coronavirus Infectious Disease Control Headquarters Pharmaceutical and Environmental Health Bureau General Affairs Division Office Contact
• About leaflet about appropriate choice of antigen qualitative test kit of new coronavirus infectious disease (PDF: 208KB)
  September 8, 2020 Ministry of Health, Labor and Welfare Novel Coronavirus Infectious Disease Control Headquarters Ministry of Health, Labor and Welfare Pharmaceutical and Environmental Health Bureau Monitoring and Guidance and Narcotics Division Office Contact
• About the handling of the expiration date of the Pako bid pack (PDF: 130KB)
  September 5, 2020
  Ministry of Health, Labor and Welfare, Pharmaceutical Safety and Environmental Health Bureau, Pharmaceutical Evaluation Division, Ministry of Health, Labor and Welfare
• Handling of expiry date of Xebdy Drip Infusion 500mg (PDF: 102KB)
  September 1, 2020 Ministry of Health, Labor and Welfare, Pharmaceutical Safety and Environmental Health Bureau, Pharmaceutical Evaluation Division
• Regarding the handling of the expiry date of Lagebrio Capsules 200mg (PDF: 106KB)
  August 30, 2020 Ministry of Health, Labor and Welfare, Pharmaceutical Safety and Environmental Health Bureau, Pharmaceutical Evaluation Division
• Regarding the handling of general-purpose new coronavirus antigen qualitative test kits during the manufacturing and sales, etc. under the epidemic of new coronavirus infectious disease (PDF: 103KB)
  August 24, 2020 PSEHB Notification No. 0824-2 Director, Medical Device Evaluation Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labor and Welfare Hemp Notification No. 0824 No. 11 Ministry of Health, Labor and Welfare, Pharmaceutical Safety and Environmental Health Bureau
• Points to note when selling general-use new coronavirus antigen qualitative test kits under the epidemic of new coronavirus infection (PDF: 363KB)
  August 24, 2020
  Ministry of Health, Labor and Welfare, Ministry of Health, Labor and Welfare, Ministry of Health, Labor and Welfare Guidance and Narcotic Control Section Office Contact
• Distribution of oral antiviral drugs (Lagebrio® Capsules) to medical institutions and pharmacies in new coronavirus infection (Attachment and Q&A collection) (PDF: 1,605KB)
  August 15, 2020 Ministry of Health, Labor and Welfare New Coronavirus Infectious Disease Control Headquarters Pharmaceutical and Environmental Health Bureau General Affairs Division Administrative Contact
• Allocation, etc. to medical institutions and pharmacies associated with the drug price listing of oral antiviral drug (Lagebrio® Capsules) for new coronavirus infection (well-known) (PDF: 164KB)
  August 10, 2020 Ministry of Health, Labor and Welfare New Coronavirus Infectious Disease Control Headquarters Pharmaceutical and Environmental Health Bureau General Affairs Division Office Contact
• Thorough implementation of infection control measures in medical settings that are effective and less burdensome (PDF: 93KB)
  August 5, 2020 Ministry of Health, Labor and Welfare Novel Coronavirus Infectious Disease Control Headquarters Ministry of Health, Labor and Welfare Health Policy Bureau General Affairs Division Health Policy Bureau Regional Medical Planning Division Administrative Contact
• Regarding the stable supply of acetaminophen preparations (PDF: 366KB)
  July 29, 2020 Administrative contact, Pharmaceutical Industry Promotion and Medical Information Planning Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• About orders for medical antigen test kits (PDF: 213KB)
  July 28, 2020
  Ministry of Health, Labor and Welfare Novel Coronavirus Infectious Disease Control Headquarters Ministry of Health, Labor and Welfare Health Policy Bureau Pharmaceutical Industry Promotion and Medical Information Planning Division
• Regarding the handling of medical antigen test kits at pharmacies under the spread of new coronavirus infections (PDF: 2,333KB)
  July 22, 2020 Ministry of Health, Labor and Welfare, Pharmaceutical Safety and Environmental Health Bureau, General Affairs Division Office contact
• About distribution of neutralizing antibody drug in new coronavirus infectious disease to medical institution (amendment of attachment and collection of questions and answers) (PDF: 600KB)
  July 1, 2020 Ministry of Health, Labor and Welfare New Coronavirus Infectious Disease Control Headquarters Office Contact
• About well-known matter to training facilities such as training schools such as medical-related occupations with outbreak of new coronavirus infectious disease (well-known) (PDF: 683KB)
  May 9, 2020 4 Fukubo Ijin No. 408 Director of Medical Policy Department, Bureau of Social Welfare and Public Health, Tokyo Metropolitan Government
• Revision of "Q&A on Temporary and Exceptional Handling of Medical Treatment Using Telephones and Information and Communication Devices during the Spread of New Coronavirus Infection" (Part 2) (PDF: 340KB)
  March 31, 2020 Medical Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• About the drug delivery support project for patients such as home medical treatment at pharmacies accompanying the implementation of medication guidance using telephones and information communication devices (PDF: 305KB)
  (Attachment) Report form (Excel: 33KB)
  February 25, 2020 Ministry of Health, Labor and Welfare, Pharmaceutical Safety and Environmental Health Bureau, General Affairs Division Office contact
• Regarding the development of a mechanism to individually respond to urgent purchase requests from medical institutions with insufficient antigen qualitative test kits (PDF: 90KB)
  February 18, 2020 Ministry of Health, Labor and Welfare Novel Coronavirus Infectious Disease Control Headquarters Ministry of Health, Labor and Welfare Health Policy Bureau Economic Affairs Division Office Contact
• Exceptions for pharmaceuticals subject to special approval (PDF: 91KB)
  February 10, 2020 PSEHB Notification No. 0210-7 Director, Pharmaceutical Evaluation Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labor and Welfare Notification No. 0210 No. 1 Director of Monitoring, Guidance and Narcotics Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labor and Welfare
• Regarding the replacement of "Regarding the handling of mobile medical treatment under the Medical Act" to respond to the new coronavirus infection (PDF: 592KB)
  February 9, 2020 Office contact, General Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• About the sales destination of the simple antigen kit (Part 5) (PDF: 2,514KB)
  January 27, 2020 Ministry of Health, Labor and Welfare, Pharmaceutical Safety and Environmental Health Bureau, General Affairs Division Office contact
• Where to sell the simple antigen kit (Part 4) (PDF: 1,611KB)
  January 14, 2020 Administrative contact, Director of General Affairs Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labor and Welfare
• Regarding the handling of the new coronavirus vaccine under the Medical Care Act (Part 6) (PDF: 111KB)
  January 14, 2020 3 Ara Kenei No. 4778 Ministry of Health, Labor and Welfare Health Policy Bureau General Affairs Division Administrative Contact
• About worker dispatch of nurse, assistant nurse to new coronavirus vaccination meeting place (PDF: 1,434KB)
  January 14, 2020 Medical Policy Notification No. 0114-9 Ministry of Health, Labor and Welfare Health Policy Bureau Director and 2 other joint notices
• About online medical treatment by doctors during home treatment or accommodation treatment (well-known) (PDF: 287KB)
  January 7, 2020 General Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• About review of medical fee score to affect inspection of new coronavirus infectious disease (well-known) (PDF: 1,079KB)
  December 28, 2021 Regional Medical Planning Division, Health Policy Bureau, Ministry of Health, Labor and Welfare Administrative contact
• Changes to Approval Conditions for Neutralizing Antibody Drugs (PDF: 92KB)
  PSEHB Notification No. 1224-20, December 24, 2021 Director of Pharmaceutical Evaluation Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labor and Welfare, and one other joint notice
• Exceptions for pharmaceuticals subject to special approval (PDF: 90KB)
  PSEHB Notification No. 1224-19, December 24, 2021 Director of Pharmaceutical Evaluation Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labor and Welfare, and 2 other joint notices
• Regarding monitoring guidance and points to note regarding the sale of antigen qualitative test kits for research on new coronavirus infections (PDF: 355KB)
  December 22, 2021 Ministry of Health, Labor and Welfare New Coronavirus Infectious Disease Control Headquarters and one other administrative contact
• Cases of visitation with attention to preventing the spread of infection at medical facilities, etc. (PDF: 1,367KB)
  November 24, 2021 Regional Medical Planning Division, Health Policy Bureau, Ministry of Health, Labor and Welfare Administrative contact
• Points to note regarding the handling of medical antigen qualitative test kits at pharmacies during the outbreak of the new coronavirus infection (PDF: 877KB)
  November 19, 2021 Ministry of Health, Labor and Welfare New Coronavirus Infectious Disease Control Headquarters and 2 other administrative contacts
• About the sales destination of the simple antigen kit (Part 3) (PDF: 1,377KB)
  November 19, 2021 Office contact, General Affairs Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labor and Welfare
• About the sales destination of the simple antigen kit (Part 2) (PDF: 2,157KB)
  October 15, 2021 Administrative contact, General Affairs Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labor and Welfare
• Treatment under the Medical Law for the development of testing systems for new coronavirus infectious diseases and clinical trials of vaccines and therapeutic drugs (PDF: 230KB)
  October 4, 2021 General Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• Exceptions for pharmaceuticals subject to special approval (PDF: 92KB)
  September 28, 2021 PSEHB Notification No. 0928-2 Director, Pharmaceutical Evaluation Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labor and Welfare, and 2 other joint notices
• About common knowledge of "continuous support for infection prevention measures" (PDF: 842KB)
  September 28, 2021 Office contact, General Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• Regarding the handling of administrative inspections related to the new coronavirus infection based on the "Handling of medical antigen test kits at pharmacies under the epidemic of the new coronavirus infection" (PDF: 53KB)
  September 27, 2021 Ministry of Health, Labor and Welfare New Coronavirus Infectious Disease Control Headquarters Office Contact
• Regarding handling of medical antigen test kits at pharmacies under the epidemic of new coronavirus infection (PDF: 341KB)
  September 27, 2021 Ministry of Health, Labor and Welfare New Coronavirus Infectious Disease Control Headquarters and one other administrative contact
• Regarding cooperation with priority use for necessary patients until stable supply of dexamethasone preparations (PDF: 381KB)
  September 9, 2021 New Coronavirus Infectious Disease Control Headquarters and 2 other administrative contacts
• Exceptions for pharmaceuticals subject to special approval (PDF: 89KB)
  July 20, 2021 PSEHB Notification No. 0720-1 Director, Pharmaceutical Evaluation Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labor and Welfare, and 2 other joint notices
• About well-known matter to training facilities such as training schools such as medical-related occupations with outbreak of new coronavirus infectious disease (well-known) (PDF: 854KB)
  June 30, 2021 3Fukubo Ijin No. 981 Notification of the Director of Medical Policy Department, Bureau of Social Welfare and Public Health, Tokyo Metropolitan Government
• About the handling when a wholesale distributor sells necessary pharmaceuticals to a clinic that is temporarily established for inoculation of vaccines related to new coronavirus infectious diseases (PDF: 79KB)
  June 30, 2021 General Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• About sales destinations of simple antigen kits (PDF: 2,419KB)
  June 28, 2021 Office contact, General Affairs Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labor and Welfare
• Temporary handling under the Medical Care Act pertaining to securing a system for prompt vaccination of new coronavirus infectious diseases (Part 5) (PDF: 299KB)
  June 24, 2021 General Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• Training for implementation by clinical laboratory technologists and paramedics for intramuscular injections for vaccination against new coronavirus infections (second report) (PDF: 361KB)
  June 17, 2021 Medical Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• About update of collection of questions and answers (Q&A) about "implementation by dentist of intramuscular injection for vaccination concerning new coronavirus infectious disease" (PDF: 78KB)
  June 15, 2021 Medical Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• Temporary handling under the Medical Care Act pertaining to securing a system for prompt vaccination of new coronavirus infectious diseases (Part 4) (PDF: 230KB)
  June 14, 2021 Office contact, General Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• About the handling such as medical office establishment when long-term care health facility inoculates new coronavirus vaccine to person except resident of own facility (PDF: 65KB)
  June 9, 2021 General Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• About the handling under the medical law of the mobile medical examination in the inspection pertaining to the new coronavirus infectious disease (PDF: 88KB)
  June 9, 2021 Office contact, General Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• About how to respond based on the expertise of each medical profession to promote vaccination against new coronavirus infections (PDF: 150KB)
  June 4, 2021 Medical Policy Notification No. 0604-31 Ministry of Health, Labor and Welfare Health Policy Bureau Director and 2 other joint notices
• About revision of "Q&A about temporary, exceptional handling such as medical treatment using telephone and information communication equipment at the time of spread of new coronavirus infectious disease" (PDF: 236KB)
  June 4, 2021 Medical Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• Supplement to "Notes on the use of coronavirus-modified uridine RNA vaccine (SARS-CoV-2) (intramuscular injection of community)" (PDF: 80KB)
  June 2, 2021 PSEHB Notification No. 0602-3 Director, Pharmaceutical Evaluation Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labor and Welfare, and one other joint notice
• Temporary handling under the Medical Care Act pertaining to securing a system for prompt vaccination of new coronavirus infectious diseases (Part 3) (PDF: 76KB)
  May 28, 2021 Office contact, General Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• About utilization of medical treatment using telephone and information communication equipment in implementation of vaccination pertaining to new coronavirus infectious disease (PDF: 104KB)
  May 25, 2021 Ministry of Health, Labor and Welfare, Health Service Division, Health Division, Immunization Office, Health Policy Bureau, Medical Affairs Division, Administrative Contact
• About Q&A about "Implementation by dentists of intramuscular injections for vaccination against new coronavirus infectious disease" (PDF: 79KB)
  May 25, 2021 Medical Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• Partial Correction of "Regarding Exceptions Concerning Pharmaceuticals Subject to Exceptional Approval" (PDF: 93KB)
  May 25, 2021 Pharmaceutical Evaluation Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labor and Welfare
• Notes on using coronavirus (SARS-CoV-2) vaccine (genetically modified simian adenovirus vector) (Bakiszebria intramuscular injection) (PDF: 187KB)
  May 21, 2021 PSEHB Notification No. 0521-9 Director, Pharmaceutical Evaluation Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labor and Welfare
• Notes on the use of coronavirus-modified uridine RNA vaccine (SARS-CoV-2) (COVID-19 vaccine model na muscle note) (PDF: 180KB)
  May 21, 2021 PSEHB Notification No. 0521-5 Director, Pharmaceutical Evaluation Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labor and Welfare
• Exceptions for pharmaceuticals subject to special approval (PDF: 81KB)
  May 21, 2021 PSEHB Notification No. 0521-1 Director, Pharmaceutical Evaluation Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labor and Welfare
• Drugs Approved as New Drugs (PDF: 69KB)
  May 21, 2021 Office contact, Pharmaceutical Evaluation Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labor and Welfare
• About training for conduct by dentist of intramuscular injection for vaccination pertaining to new coronavirus infectious disease (PDF: 118KB)
  May 11, 2021 Medical Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• Information on training materials related to response to new coronavirus infectious diseases for non-medical professionals such as nursing assistants (PDF: 73KB)
  (Reference) Securing a medical care provision system to respond to the increase in hospitalized patients due to the spread of infection (Administrative communication dated December 25, 2020) (PDF: 205KB)
  May 10, 2021 Nursing Service Promotion Office, Health Policy Bureau, Ministry of Health, Labor and Welfare
• About conduct by dentist of intramuscular injection for vaccination to affect new coronavirus infectious disease (PDF: 110KB)
  April 26, 2021 Medical Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• About "quality control manual in PCR test of new coronavirus infectious disease" (well-known) (PDF: 266KB)
  April 16, 2021 Ministry of Health, Labor and Welfare New Coronavirus Infectious Disease Control Headquarters Office Contact
• About ventilation equipment when treating new coronavirus infections (PDF: 344KB)
  April 7, 2021 Ministry of Health, Labor and Welfare New Coronavirus Infectious Disease Control Headquarters and other office contact
• About a partial correction of "Considerations for the use of coronavirus-modified uridine RNA vaccine (SARS-CoV-2) (intramuscular injection of community)" (PDF: 165KB)
  February 16, 2021 Pharmaceutical Evaluation Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labor and Welfare, and one other administrative contact
• Exceptions for pharmaceuticals subject to special approval (PDF: 70KB)
  February 14, 2021 PSEHB Notification No. 0214-5 Director, Pharmaceutical Evaluation Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labor and Welfare
• Precautions regarding the use of coronavirus-modified uridine RNA vaccine (SARS-CoV-2) (Community intramuscular injection) (PDF: 150KB)
  PSEHB Notification No. 0214-1 on February 14, 2021 Director of Pharmaceutical Evaluation Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labor and Welfare, and one other joint notice
• Regarding requests for cooperation for those who provide self-inspection for new coronavirus infectious diseases based on the revised Infectious Disease Law (PDF: 196KB)
  February 10, 2021 Medical Policy Notification No. 0210 No. 2 Director of Health Policy Bureau, Ministry of Health, Labor and Welfare and 1 other joint notice
• Regarding the handling of bedding that is at risk of being infected with the new coronavirus at medical institutions due to the partial revision of the Act on Prevention of Infectious Diseases and Medical Care for Patients with Infectious Diseases (PDF: 727KB)
  February 8, 2021 Health Policy Notification No. 0208 No. 5 Notification from the Director of the Health Policy Bureau, Ministry of Health, Labor and Welfare
• Temporary handling under the Medical Care Act pertaining to securing a system for prompt vaccination of new coronavirus infectious diseases (Part 2) (PDF: 340KB)
  February 1, 2021 Office contact, General Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• About common knowledge to affect the handling such as facilities for firefighting for new coronavirus infectious disease measures (PDF: 612KB)
  January 27, 2021 Office contact, General Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• Points to note when issuing a prescription to a patient suspected of being infected with the new coronavirus at medical institutions, etc. (PDF: 1,422KB)
  December 24, 2020 Ministry of Health, Labor and Welfare New Coronavirus Infectious Disease Control Headquarters and other office contact
• About self-inspection about new coronavirus infectious disease (information provision) (PDF: 89KB)
  December 18, 2020 Ministry of Health, Labor and Welfare New Coronavirus Infectious Disease Control Headquarters Office Contact
• Temporary handling under the Medical Care Act pertaining to ensuring the system for prompt vaccination of new coronavirus infectious diseases (PDF: 151KB)
  December 17, 2020 Office contact, General Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• Securing enough ventilators in preparation for the increase in the number of patients with new coronavirus infections (Request 3) (PDF: 965KB)
  November 26, 2020 Ministry of Health, Labor and Welfare New Coronavirus Infectious Disease Control Headquarters and one other administrative contact
• Regarding the publicity of matters that inspection organizations that carry out self-inspections regarding new coronavirus infections should provide information and requests for cooperation (PDF: 180KB)
  November 24, 2020 Ministry of Health, Labor and Welfare New Coronavirus Infectious Disease Control Headquarters Office Contact
• About point to keep in mind for prevention of infection spread in medical facilities (2) (PDF: 1,003KB)
  October 15, 2020 General Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• About further support to medical institutions using contingency funds (PDF: 1,082KB)
  October 13, 2020 Office contact, General Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• About the handling in the medical law pertaining to changes such as medical examination hours pertaining to outpatient medical examination and inspection system securing of fever patients in preparation for influenza epidemic season (PDF: 60KB)
  Reference About system maintenance for the next influenza epidemic (PDF: 291KB)
  October 6, 2020 Office contact, General Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• Matters to note regarding temporary and exceptional handling of medical care using telephones and information communication devices in the event of the spread of new coronavirus infections (response at pharmacies) (PDF: 118KB)
  September 4, 2020 Office contact, General Affairs Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labor and Welfare
• About implementation method of training implementation outline pertaining to health support pharmacy based on correspondence to new coronavirus infectious disease (PDF: 297KB)
  September 1, 2020 Administrative contact, General Affairs Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labor and Welfare
• Matters to consider regarding temporary and exceptional handling of medical care using telephones and information communication equipment during the spread of new coronavirus infections (PDF: 140KB)
  Attachment 1 Implementation status (survey form) (Excel: 16KB)
  August 26, 2020 Medical Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• About the handling of advertisement about medical practice or dental practice based on new coronavirus infectious disease or hospital or clinic (PDF: 1,522KB)
  August 6, 2020 Office contact, General Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• About voluntary inspection for nosocomial infection measures in medical institution (PDF: 1,048KB)
  July 31, 2020 Ministry of Health, Labor and Welfare New Coronavirus Infectious Disease Control Headquarters Office Contact
• About common knowledge of medical institution, medical worker support measures (PDF: 2,834KB)
  July 17, 2020 Office contact, General Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• About distribution of high-concentration ethanol product accompanied with new coronavirus infectious disease (partial change) (PDF: 102KB)
  June 24, 2020 Health Policy Department, Bureau of Social Welfare and Public Health, Tokyo Metropolitan Government
• About distribution of surgical masks to clinics and dental clinics due to new coronavirus infection (partial change) (PDF: 149KB)
  June 24, 2020 Health Policy Department, Bureau of Social Welfare and Public Health, Tokyo Metropolitan Government
• Consideration of dental care provision system and provision of dental health care with an eye on the future based on the cancellation of the emergency declaration related to the new coronavirus infectious disease (request) (PDF: 162KB)
  June 19, 2nd year of Reiwa Medical Policy 0619 No. 1 Notice from Director of Dental Health Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• About financing for medical facilities that have stopped functioning due to the new coronavirus infection (PDF: 1,184KB)
  June 16, 2020 Tokyo Metropolitan Government Bureau of Social Welfare and Public Health, Health Safety Department, Infectious Disease Control Division, and one other administrative contact
• About distribution of surgical masks to clinics and dental clinics due to new coronavirus infection (PDF: 117KB)
  June 5, 2020 Health Policy Department, Bureau of Social Welfare and Public Health, Tokyo Metropolitan Government
• Points to note regarding medical treatment for people suspected of having new coronavirus infection (Part 2) (PDF: 164KB)
  June 2, 2020 Ministry of Health, Labor and Welfare New Coronavirus Infectious Disease Control Headquarters Office Contact
• Points to note regarding the delivery of drugs at medical institutions to patients undergoing home treatment in the temporary and exceptional handling of medical care using telephones and information communication devices during the spread of new coronavirus infections (PDF: 131 KB )
  June 2, 2020 Office contact, General Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• Extension of the transitional period for methylphenidate hydrochloride preparations (Conserta Tablets 18mg, 27mg and 36mg) due to the impact of the novel coronavirus infection (PDF: 143KB)
  May 27, 2020 PSEHB No. 0527-1 Director of General Affairs Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labor and Welfare
• Points to note when issuing prescriptions to patients suspected of being infected with the new coronavirus at outpatient clinics for returnees and contacts (PDF: 98KB)
  May 27, 2020 Ministry of Health, Labor and Welfare Novel Coronavirus Countermeasures Headquarters and other office contact
• Providing information on an online training system for dentists to collect nasal and pharyngeal swabs for PCR testing on new coronavirus infections) (PDF: 307KB)
  May 21, 2020 Medical Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• Regarding the release of training videos for dentists to collect nasal and pharyngeal swabs for PCR testing on new coronavirus infections (PDF: 113KB)
  May 20, 2020 Medical Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• About surplus dairy products due to school closure (PDF: 387KB)
  May 18, 2020 Office contact, General Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• Q&A regarding temporary and exceptional handling of medical treatment using telephones and information communication devices during the spread of new coronavirus infections in dental practice (PDF: 210KB)
  May 18, 2020 Ministry of Health, Labor and Welfare, Health Policy Bureau, Dental Health Division and 1 other administrative contact
• About distribution of high-concentration ethanol product accompanied with new coronavirus infectious disease (PDF: 529KB)
  May 15, 2020 Health Policy Department, Bureau of Social Welfare and Public Health, Tokyo Metropolitan Government
• About extension of period of medical institution investigation about ventilator maintenance for patient increase of new coronavirus infectious disease (request) (PDF: 1,710KB)
  May 15, 2020 Ministry of Health, Labor and Welfare New Coronavirus Infectious Disease Control Headquarters and other office contact
• Q&A on "Concerning the collection of nasal and pharyngeal swabs by dentists for PCR testing on new coronavirus infections" (PDF: 83KB)
  May 15, 2020 Medical Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• About temporary handling in medical law to affect local outpatient, examination center administration (PDF: 137KB)
  May 13, 2020 Office contact, General Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• Regarding the handling of operations that are required to be performed regularly under the Medical Care Act, etc. due to the effects of the new coronavirus infection (PDF: 106KB)
  May 12, 2020 Health Policy Bureau, Ministry of Health, Labor and Welfare
• About revision of supplementary material about medical care system corresponding to new coronavirus infectious disease of child (PDF: 1,290KB)
  May 12, 2020 Ministry of Health, Labor and Welfare New Coronavirus Infectious Disease Control Headquarters Office Contact
• About implementation method of medical institution investigation about ventilator maintenance for patient increase of new coronavirus infectious disease (request) (PDF: 1,780KB)
  May 12, 2020 Ministry of Health, Labor and Welfare New Coronavirus Infectious Disease Control Headquarters and other office contact
• Handling of omission of stamping in administrative procedures related to pharmaceutical laws and regulations in response to new coronavirus infection (PDF: 73KB)
  May 8, 2020 Office contact, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labor and Welfare
• Notes on the use of remdesivir preparations (PDF: 130KB)
  May 7, 2020 PSEHB Notification No. 0507-12 Director, Pharmaceutical Evaluation Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labor and Welfare
• Consideration for pregnant doctors, nurses, etc. to prevent the spread of new coronavirus infections (PDF: 143KB)
  May 7, 2020 Health Policy Bureau, Ministry of Health, Labor and Welfare
• About Q&A about temporary, exceptional handling such as medical treatment using telephone and information communication equipment at the time of spread of new coronavirus infectious disease (PDF: 228KB)
  May 1, 2020 Medical Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• About system maintenance for new coronavirus infectious disease outbreak in medical institution and initial correspondence at the time of outbreak (PDF: 189KB)
  May 1, 2020 Ministry of Health, Labor and Welfare New Coronavirus Infectious Disease Control Headquarters Office Contact
• Request for publicity about reports such as side effects of pharmaceuticals from medical personnel related to new coronavirus infectious disease) (PDF: 686KB)
  May 1, 2020 Ministry of Health, Labor and Welfare New Coronavirus Infectious Disease Control Headquarters and one other administrative contact
• About medical institution investigation about ventilator maintenance for patient increase of new coronavirus infectious disease (request) (PDF: 695KB)
  April 30, 2020 Ministry of Health, Labor and Welfare New Coronavirus Infectious Disease Control Headquarters and other office contact
• About the implementation status report of medical institutions that carry out medical treatment using telephones and information communication equipment in the event of the spread of new coronavirus infectious disease (information provision) (PDF: 181KB)
  April 30, 2020 Health Policy Division, Health Policy Department, Bureau of Social Welfare and Public Health, Tokyo Metropolitan Government
  Click here for the Tokyo Metropolitan Government website regarding the report (link to an external site) (opens in a new window)
• Regarding the creation of a list of medical institutions that provide medical care using telephones and information communication devices during the spread of new coronavirus infection in dental practice and reporting on the implementation status (PDF: 469KB)
  April 30, 2020 Tokyo Metropolitan Government Bureau of Social Welfare and Public Health Medical Policy Department Dentistry Section Director
  Click here for the Tokyo Metropolitan Government website regarding the report (link to an external site) (opens in a new window)
• About the drug delivery support project at pharmacies accompanying the implementation of medication guidance using telephones and information communication devices (PDF: 928KB)
  April 30, 2020 Ministry of Health, Labor and Welfare, Pharmaceutical Safety and Environmental Health Bureau, General Affairs Division Office contact
• Points to note regarding drug delivery methods to patients undergoing home medical treatment in the case of temporary/special treatment such as medical treatment using telephones and information communication devices during the spread of new coronavirus infections (PDF: 580KB)
  April 28, 2020 Administrative contact, General Affairs Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labor and Welfare
• About the handling of the Personal Information Protection Law when sharing personal information between medical institutions related to the new coronavirus infection (PDF: 554KB)
  April 28, 2020 Office contact, General Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• Concerning implementation by dentists of collecting swabs of nasal cavity and pharynx for PCR tests on new coronavirus infections (PDF: 174KB)
  April 27, 2020 Medical Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• Regarding the handling of bedding that is at risk of being infected with the new coronavirus at medical institutions (PDF: 575KB)
  April 24, 2020 Ministry of Health, Labor and Welfare Health Policy Bureau Regional Medical Planning Division Office Contact
• Temporary and exceptional handling of medical treatment using telephones and information communication devices during the spread of new coronavirus infections in dental practice (PDF: 44KB)
  April 24, 2020 Dental Health Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• About use of high concentration ethanol product with outbreak of new coronavirus infectious disease (April 22, 2020 revision) (PDF: 120KB)
  April 22, 2020 Economic Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• Regarding the handling of high-concentration ethanol products at pharmacies, etc. due to the outbreak of the new coronavirus infection (Revised on April 22, 2020) (PDF: 199KB)
  April 22, 2020 General Affairs Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labor and Welfare
• Exceptional handling of single-use components of ventilators at medical institutions in light of the spread of new coronavirus infections (PDF: 455KB)
  April 21, 2020 Health Policy Bureau, Ministry of Health, Labor and Welfare
• About the medical care system to affect pediatric patient of new coronavirus infectious disease (notification) (PDF: 1,515KB)
  April 20, 2020
  2Fukubo Ikyu No. 158 Health and Safety Department, Bureau of Social Welfare and Public Health, Tokyo Metropolitan Government
• About conduct of emergency medical care about patient doubting new coronavirus infectious disease (PDF: 107KB)
  April 18, 2020 Ministry of Health, Labor and Welfare Novel Coronavirus Infectious Disease Control Headquarters Office Contact
• Exceptional handling of single-use components of ventilators by manufacturers in light of the spread of new coronavirus infections (PDF: 159KB)
  April 16, 2020 Health Policy Bureau, Ministry of Health, Labor and Welfare
• Temporary and exceptional handling of medical treatment using telephones and information communication equipment during the spread of new coronavirus infections (PDF: 463KB)
  April 10, 2020 Medical Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• About offer to other companies of ethanol for disinfection (PDF: 399KB)
  April 9, 2020 General Affairs Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labor and Welfare
• About correspondence to new coronavirus infectious disease in medical institution (3) (PDF: 1,036KB)
  April 7, 2020 Ministry of Health, Labor and Welfare New Coronavirus Infectious Disease Control Headquarters Office Contact
• About surgical mask distribution to dental clinic concerned with prevention of infection spread of new coronavirus infectious disease (PDF: 255KB)
  Tokyo Metropolitan Government Bureau of Social Welfare and Public Health "Notice from the Medical Safety Division" (link to an external site) (opens in a separate window)
  April 7, 2020 Health Policy Department, Bureau of Social Welfare and Public Health, Tokyo Metropolitan Government
• In-hospital infection measures to prevent the spread of new coronavirus infection in dental institutions (PDF: 125KB)
  April 6, 2020 Ministry of Health, Labor and Welfare, Health Policy Bureau, Dental Health Division Office contact
• Appropriate implementation of health observations and information sharing in response to the new coronavirus infection (request) (PDF: 118KB)
  April 2, 2020 Ministry of Health, Labor and Welfare New Coronavirus Infectious Disease Control Headquarters Office Contact
• About the handling in the medical law of mobile medical treatment pertaining to new coronavirus infectious disease (PDF: 55KB)
  March 25, 2020 Office contact, General Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• About genetic test method of administrative inspection about new coronavirus (PDF: 249KB)
• FY2019 Institutional Facility Development Plan for Testing for New Coronavirus Infectious Diseases (Excel: 18KB)
  March 18, 2020 Ministry of Health, Labor and Welfare Health Service Bureau Tuberculosis and Infectious Diseases Division Administrative Contact
• About correspondence to small and medium-sized enterprises based on influence by outbreak and spread of new coronavirus infectious disease (well-known) (PDF: 88KB)
• (Attachment) Responses to SMEs, etc. in light of the impact of the outbreak and spread of the new coronavirus infectionPDF: 121KB)
  March 17, 2020 Office contact, General Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• About the tax payment grace system when it is difficult to pay tax due to the influence of the new coronavirus infectious disease (PDF: 584KB)
  March 16, 2020 Office contact, General Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• About point to keep in mind when person whom new coronavirus infectious disease was doubted visited pharmacy (PDF: 136KB)
  March 13, 2020 Ministry of Health, Labor and Welfare, Pharmaceutical Safety and Environmental Health Bureau, General Affairs Division Office contact
• Points to note regarding medical care for people suspected of having new coronavirus infection PDF: 158KB)
  March 11, 2020 Ministry of Health, Labor and Welfare New Coronavirus Infectious Disease Control Headquarters Office Contact
• About the second emergency countermeasures for the new coronavirus infection (PDF: 807KB)
  March 10, 2020 Office contact, General Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• About the handling when I establish a hygiene laboratory temporarily to perform only pathogen nucleic acid examination to affect new coronavirus infectious disease (PDF: 330KB)
  March 5, 2020 Health Policy Notification No. 0305 No. 1 Notification from the Director of the Health Policy Bureau, Ministry of Health, Labor and Welfare
• About correspondence to new coronavirus infectious disease in organ transplantation and hematopoietic stem cell transplantation (PDF: 441KB)
  March 5, 2nd year of Reiwa Notification of Kentohatsu 0305 No. 2 Director of Transplant Medicine Promotion Office, Health Service Bureau, Ministry of Health, Labor and Welfare
• Temporary handling under the Medical Law regarding the handling of medical radiation for new coronavirus infections (PDF: 105KB)
  March 4, 2020 Ministry of Health, Labor and Welfare Health Policy Bureau Regional Medical Planning Division Office Contact
• About correspondence such as medical institution, social welfare facility in connection with temporary closure of school for prevention of new coronavirus infectious disease (PDF: 1,212KB)
  February 28, 2020 Health Policy Bureau, Ministry of Health, Labor and Welfare, etc. Only Attachments 2, 3, 4, and 5 for medical institutions are posted after the administrative contact text.
• About temporary handling on medical fees pertaining to new coronavirus infectious disease (Part 2) (PDF: 183KB)
  February 28, 2020 Ministry of Health, Labor and Welfare, Health Insurance Bureau, Medical Affairs Division Office contact
• About points to keep in mind for prevention of infection spread in medical facilities (PDF: 143KB)
  February 25, 2020 General Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• About correspondence to new coronavirus infectious disease in medical institution (2) (PDF: 349KB)
  February 21, 2020 Regional Medical Planning Division, Health Policy Bureau, Ministry of Health, Labor and Welfare Administrative contact
• About the handling of event holding based on outbreak of new coronavirus infectious diseasePDF: 99KB)
• Minister's message to the people regarding the holding of the event) (PDF: 59KB)
  February 21, 2020 Office contact, General Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• About the handling of event holding based on outbreak of new coronavirus infectious disease (PDF: 101KB)
• Minister's message to the people regarding the holding of the event) (PDF: 59KB)
  February 21, 2020 Office contact, General Affairs Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labor and Welfare
• About correspondence based on "indication of consultation, consultation about new coronavirus infectious disease" (for drugstore, drug dealer) (PDF: 92KB)
• Attachment Guideline for consultation/consultation about new coronavirus infectious disease (PDF: 118KB)
  February 18, 2020 Administrative contact, General Affairs Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labor and Welfare
• For medical institutions) (PDF: 75KB)
• Indication of consultation, consultation about new coronavirus infectious diseasePDF: 119KB)
• To prevent new coronavirus (flyer) (PDF: 160KB)
  February 18, 2020 Office contact, General Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• About temporary handling on the medical law pertaining to new coronavirus infectious disease (PDF: 108KB)
  February 17, 2020 General Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• Procedures under the Medical Care Act to deal with the new coronavirus infection (PDF: 320KB)
  February 16, 2020 General Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• About correspondence to new coronavirus infectious disease in medical institution (PDF: 92KB)
  February 13, 2020 Ministry of Health, Labor and Welfare Health Policy Bureau Regional Medical Planning Division Office Contact
• About acceptance of inpatients such as new coronavirus infectious disease patients (PDF: 126KB)
  February 10, 2020 General Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare
• About securing of hospitalization bed such as new coronavirus infectious disease patients (request) (PDF: 138KB)
• Reference: Standards for infectious disease designated medical institutions established by the Minister of Health, Labor and Welfare based on the provisions of Article 38, Paragraph 2 of the Act on Prevention of Infectious Diseases and Medical Care for Patients with Infectious Diseases (PDF: 79KB)
• Reference: About guide about facility standard of infectious disease designated medical institution (PDF: 278KB)
  February 9, 2020 Ministry of Health, Labor and Welfare Health Service Bureau Tuberculosis and Infectious Diseases Division Administrative Contact
• About correspondence to new coronavirus infectious disease in medical facilities (PDF: 164KB)
• Reference December 19, 2014 Isei Chihatsu 1219 No. 1 Measures against nosocomial infections in medical institutions (PDF: 155KB)
• Reference Response to new coronavirus infection and measures against hospital infection (Revised January 21, 2020) (PDF: 915KB)
  January 31, 2020 General Affairs Division, Health Policy Bureau, Ministry of Health, Labor and Welfare

Related information

• List of information (new coronavirus infectious disease) for the local government, medical institution (link to the outside site) (open with the other window)
  Ministry of Health, Labor and Welfare website
• About medical safety measures Ministry of Health, Labor and Welfare homepage) (link to the outside site) (open with the other window)
• Medical safety measures laws and ordinances, notice (Ministry of Health, Labor and Welfare homepage) (link to the outside site) (open with the other window)
• Safety information for pharmaceuticals and medical devices (Ministry of Health, Labor and Welfare website) (link to an external site) (opens in a separate window)
• Japan Council for Quality Health Care (link to an external site) (opens in a new window)
• "Medical safety information" (Japan Council for Quality Health Care) (link to an external site) (opens in a separate window)
• "Medical Adverse Event Information Collection Project Report / Annual Report" (Japan Council for Quality Health Care) (link to an external site) (opens in a new window)
• Pharmaceuticals and Medical Devices Information Website (Pharmaceuticals and Medical Devices Agency) (link to external site) (opens in a new window)